429
Participants
Start Date
February 24, 2021
Primary Completion Date
September 24, 2024
Study Completion Date
December 24, 2024
Ivabradine
Ivabradine will be administered via the enteral route, every 12 hours, at doses ranging from 2.5 to 5 mg to achieve a target heart rate between 80 and 94 bpm
Ivabradine
Ivabradine will be administered via the enteral route, every 12 hours, at doses ranging from 5 to 7.5 mg to achieve a target heart rate between 80 and 94
Placebo
Placebo will be administered via the enteral route, every 12 hours.
RECRUITING
Henri Mondor Hospital, Créteil
Assistance Publique - Hôpitaux de Paris
OTHER